SCHEMBL3308197

SCHEMBL3308197

CCOC(=O)C1(N)Cc2ccc(Cl)c(Cl)c2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 5/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
CYP4F2 P78329 1/20 0.35
CYP4A11 Q02928 1/20 0.35
BRD4 O60885 1/20 0.35
SLC6A3 Q01959 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A2 P23975 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CYP2C9 P11712 3/20 0.34
KDM4E B2RXH2 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C19 P33261 2/20 0.34
HIF1A Q16665 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ADRA1A P35348 2/20 0.34
OPRK1 P41145 2/20 0.34
MAPT P10636 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3304544 0.84 BRD4 (0.40) OPRM1MEN1KMT2ABRD4SLC6A3
SCHEMBL13328476 0.80 OPRM1 (0.45) OPRM1MEN1KMT2ACYP4F2CYP4A11
Hydrochloric Acid SCHEMBL4835381 0.79 OPRM1 (0.47) OPRM1MEN1KMT2ACYP4F2CYP4A11
SCHEMBL3304678 0.78 OPRM1 (0.37) OPRM1MEN1KMT2ABRD4SLC6A4
SCHEMBL13328485 0.78 MEN1 (0.46) OPRM1MEN1KMT2ASMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL3306425 0.77 OPRM1 (0.39) OPRM1MEN1KMT2ABRD4SLC6A4
SCHEMBL3501478 0.77 BRD4 (0.41) OPRM1MEN1KMT2ABRD4SLC6A4
SCHEMBL3306445 0.76 BRD4 (0.51) OPRM1MEN1KMT2ABRD4SLC6A4
SCHEMBL30801469 0.76 BRD4 (0.51) OPRM1MEN1KMT2ABRD4SLC6A4
SCHEMBL13328493 0.76 BRD4 (0.40) OPRM1KMT2ABRD4SLC6A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8569535-B2 Substituted benzoylamino-indan-2-carboxylic acids and related compounds SANOFI (FR) 2013-10-29 US disclosed
US-20100113462-A1 SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS SANOFI-AVENTIS (FR) 2010-05-06 US disclosed
EP-2155711-A1 SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS Sanofi-Aventis (FR) 2010-02-24 EP disclosed
WO-2008151211-A1 SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS SANOFI-AVENTIS (FR) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113462-A1 SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS CXCR5, CXCR1, CCR5 OPRM1 619/4885MEN1 3627/4885KMT2A 4037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.